Citius Oncology (CTOR) Shares Outstanding (Diluted) (2021 - 2026)
Citius Oncology (CTOR) reported Weighted Average Shares Outstanding (Diluted) of 107.89 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 50.8% from 71.55 million a year earlier and up 7.9% from the prior quarter.
Citius Oncology (CTOR) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Citius Oncology posted Weighted Average Shares Outstanding (Diluted) of 73.27 million, up 7.7% from FY2024.
- Weighted Average Shares Outstanding (Diluted) has a three-year compound annual growth rate of 183.7% (FY2022 to FY2025).
- By fiscal year, Weighted Average Shares Outstanding (Diluted) came in at 68.05 million in FY2024, 67.5 million in FY2023 and 3.21 million in FY2022.
- The fiscal Q3 2026 figure ranks as the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to fiscal Q3 2022.
- Year over year, Weighted Average Shares Outstanding (Diluted) has now increased in each of the last four quarters, with growth averaging 30.1% over the last four quarters.
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at 100.03 million (Q2 2026), 87.46 million (Q1 2026) and 73.27 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Citius Oncology | 60.42 Mn | 30.00 Mn | 1.00 Mn | 107.89 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 107.89 Mn |
| Mar 31, 2026 | 100.03 Mn |
| Dec 31, 2025 | 87.46 Mn |
| Sep 30, 2025 | 73.27 Mn |
| Jun 30, 2025 | 71.55 Mn |
| Mar 31, 2025 | 71.55 Mn |
| Dec 31, 2024 | 71.55 Mn |
| Sep 30, 2024 | 68.05 Mn |
| Jun 30, 2024 | 4.31 Mn |
| Mar 31, 2024 | 4.74 Mn |
| Dec 31, 2023 | 67.50 Mn |
| Sep 30, 2023 | 8.94 Mn |
| Jun 30, 2023 | 9.02 Mn |
| Mar 31, 2023 | 9.02 Mn |
| Dec 31, 2022 | 3.21 Mn |
| Sep 30, 2022 | 1.50 Mn |
| Mar 31, 2022 | 1.73 Mn |
| Dec 31, 2021 | 1.73 Mn |
Citius Oncology Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CTOR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "CTOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CTOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();